GlassScriptPhysician profile
Steven M Dresner
NPI 1598745481
$7,046.65
in general payments reported to CMS, 2019-2025
34 companies · $4,242 in 2025
The $4,242 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $847 · 2020: $299 · 2021: $442 · 2022: $366 · 2023: $472 · 2024: $378 · 2025: $4,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,722 · Travel and Lodging: $1,343 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,722.33 |
| Travel and Lodging | $1,343.43 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $3,531.54 | 2025 | |
| Janssen Biotech, INC. | $626.85 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $306.95 | 2019-2020 | |
| Convatec INC. | $267.80 | 2020-2023 | |
| Agiliti Health, INC. | $257.67 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology |
| Pfizer INC. | $254.32 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $228.83 | 2019-2024 | Provenge |
| Boston Scientific Corporation | $187.89 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Solyx Sis System |
| Progenics Pharmaceuticals, INC. | $157.29 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $127.69 | 2019-2025 | Lynparza |
| Travere Therapeutics, INC. | $115.71 | 2019-2021 | |
| Myovant Sciences INC. | $110.41 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $92.25 | 2023-2025 | Urgent PC Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $84.90 | 2025 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $84.89 | 2023-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $68.73 | 2024 | |
| Alnylam Pharmaceuticals INC. | $66.72 | 2021-2022 | |
| Abbvie INC. | $56.95 | 2019-2024 | Lupron Depot |
| Sumitomo Pharma America, INC. | $48.32 | 2024-2025 | Orgovyx |
| Blue Earth Diagnostics | $43.87 | 2020-2023 | |
| Endo Pharmaceuticals INC. | $43.10 | 2020-2022 | |
| Amgen INC. | $35.93 | 2020-2021 | |
| Olympus America INC. | $35.22 | 2025 | Itind System |
| Genzyme Corporation | $27.73 | 2019 | |
| Axonics, INC. | $24.32 | 2020 | |
| Cook Medical LLC | $23.99 | 2024 | Cook |
| Galvanize Therapeutics, INC | $21.52 | 2025 | Aliya System |
| Sun Pharmaceutical Industries INC. | $21.10 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.48 | 2024 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $18.67 | 2021 | |
| Coloplast Corp | $17.00 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $14.73 | 2019 | |
| Antares Pharma, INC. | $12.41 | 2021 | |
| Urovant Sciences INC | $11.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dresner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.